An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity. (2023)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.ppat.1011323
PubMed Identifier: 37134108
Publication URI: http://europepmc.org/abstract/MED/37134108
Type: Journal Article/Review
Volume: 19
Parent Publication: PLoS pathogens
Issue: 5
ISSN: 1553-7366